Log in

NYSE:HUM - Humana Stock Price, Forecast & News

$365.72
+0.85 (+0.23 %)
(As of 01/23/2020 06:31 AM ET)
Today's Range
$360.93
Now: $365.72
$368.10
50-Day Range
$342.26
MA: $361.98
$375.00
52-Week Range
$225.65
Now: $365.72
$376.39
Volume560,981 shs
Average Volume767,657 shs
Market Capitalization$48.43 billion
P/E Ratio19.43
Dividend Yield0.60%
Beta0.92
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. Read More…

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP44485910
Phone502-580-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$56.91 billion
Cash Flow$18.83 per share
Book Value$74.95 per share

Profitability

Net Income$1.68 billion

Miscellaneous

Employees41,600
Market Cap$48.43 billion
Next Earnings Date2/5/2020 (Confirmed)
OptionableOptionable

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.


Humana (NYSE:HUM) Frequently Asked Questions

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Thursday, October 24th. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.55 per share on Friday, January 31st. This represents a $2.20 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Monday, December 30th. View Humana's Dividend History.

How were Humana's earnings last quarter?

Humana Inc (NYSE:HUM) announced its earnings results on Wednesday, November, 6th. The insurance provider reported $5.03 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $4.58 by $0.45. The insurance provider earned $16.24 billion during the quarter, compared to analyst estimates of $16.15 billion. Humana had a return on equity of 22.32% and a net margin of 4.06%. The firm's quarterly revenue was up 14.3% on a year-over-year basis. During the same quarter last year, the firm earned $4.58 earnings per share. View Humana's Earnings History.

When is Humana's next earnings date?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Humana.

How can I listen to Humana's earnings call?

Humana will be holding an earnings conference call on Wednesday, February 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Humana issued on next quarter's earnings?

Humana updated its FY 2019 After-Hours earnings guidance on Monday, December, 2nd. The company provided earnings per share guidance of 17.75-17.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $17.77.

What price target have analysts set for HUM?

16 brokers have issued 12-month target prices for Humana's shares. Their forecasts range from $290.00 to $448.00. On average, they anticipate Humana's stock price to reach $355.75 in the next year. This suggests that the stock has a possible downside of 2.7%. View Analyst Price Targets for Humana.

What is the consensus analysts' recommendation for Humana?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Humana.

Has Humana been receiving favorable news coverage?

News coverage about HUM stock has been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Humana earned a coverage optimism score of 2.0 on InfoTrie's scale. They also assigned news articles about the insurance provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Humana.

Are investors shorting Humana?

Humana saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 2,180,000 shares, an increase of 13.0% from the December 15th total of 1,930,000 shares. Based on an average daily trading volume, of 957,000 shares, the days-to-cover ratio is presently 2.3 days. Currently, 1.7% of the shares of the company are sold short. View Humana's Current Options Chain.

Who are some of Humana's key competitors?

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Mastercard (MA), Walt Disney (DIS), Visa (V), Alibaba Group (BABA), Boeing (BA), JPMorgan Chase & Co. (JPM), salesforce.com (CRM) and Netflix (NFLX).

Who are Humana's key executives?

Humana's management team includes the folowing people:
  • Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 57)
  • Mr. Brian Andrew Kane, Chief Financial Officer (Age 46)
  • Mr. Timothy S. Huval, Chief HR Officer (Age 53)
  • Ms. Jody L. Bilney, Chief Consumer Officer (Age 58)
  • Dr. William Kevin Fleming Pharm.D., PharmD, RPh, Segment Pres of Healthcare Services (Age 51)

Who are Humana's major shareholders?

Humana's stock is owned by a number of of institutional and retail investors. Top institutional investors include Calamos Advisors LLC (0.17%), Artemis Investment Management LLP (0.16%), PGGM Investments (0.07%), Scout Investments Inc. (0.06%), Nisa Investment Advisors LLC (0.05%) and Rhenman & Partners Asset Management AB (0.05%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James J /Ky Obrien, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Which institutional investors are selling Humana stock?

HUM stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, Coronation Fund Managers Ltd., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Atlas Brown Inc., State of Alaska Department of Revenue, FormulaFolio Investments LLC, Stock Yards Bank & Trust Co. and B & T Capital Management DBA Alpha Capital Management. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Christopher H Hunter, Elizabeth D Bierbower, James J /Ky Obrien, Roy A Beveridge, Timothy Alan Wheatley and Timothy S Huval. View Insider Buying and Selling for Humana.

Which institutional investors are buying Humana stock?

HUM stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Scout Investments Inc., DNB Asset Management AS, Artemis Investment Management LLP, Rhenman & Partners Asset Management AB, Commerzbank Aktiengesellschaft FI, TrimTabs Asset Management LLC and Sciencast Management LP. View Insider Buying and Selling for Humana.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $365.72.

How big of a company is Humana?

Humana has a market capitalization of $48.43 billion and generates $56.91 billion in revenue each year. The insurance provider earns $1.68 billion in net income (profit) each year or $14.55 on an earnings per share basis. Humana employs 41,600 workers across the globe.View Additional Information About Humana.

What is Humana's official website?

The official website for Humana is http://www.humana.com/.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected]


MarketBeat Community Rating for Humana (NYSE HUM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  762 (Vote Outperform)
Underperform Votes:  800 (Vote Underperform)
Total Votes:  1,562
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel